UAB Wellgem Biopharma Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 139,741 |
| 49,032 |
| 123,360 |
| -123,360 |
| -43,284 |
| 7.40 |
| -88.28 |
| -28,858 |
| 1,531,301 |
| 1,416,081 |
| 85,962 |
| 2023 |
|---|
| 298,561 |
| 44,964 |
| -309,729 |
| -309,729 |
| -46,646 |
| 93.13 |
| -103.74 |
| -332,427 |
| 1,999,702 |
| 1,480,036 |
| 185,537 |
| 2024 |
|---|
| 137,620 |
| 14,456 |
| -419,214 |
| -419,214 |
| -44,035 |
| -6.75 |
| -304.62 |
| -751,641 |
| 7,251,641 |
| 4,223,088 |
| 2,375,290 |
Register and
explore Okredo data| 2024 |
|---|
| 137,620 |
| 14,456 |
| -419,214 |
| -419,214 |
| -44,035 |
| -6.75 |
| -304.62 |
| -751,641 |
| 7,251,641 |
| 4,223,088 |
| 2,375,290 |
Register and
explore Okredo data2024
Turnover (€)
137,620 €
-54 % *
Sales per employee (€)
14,456 €-68 % *
Profit before tax (€)
-419,214 €-35 % *
Net Profit (€)
-419,214 €-35 % *
Profit per employee (€)
-44,035 €
6 % *
Total profitability (%)
-6.75 %-107.25 % *
Net profitability (%)
-304.62 %-193.64 % *
Equity (€)
-751,641 €-126 % *
Amounts Payable And Liabilities (€)
7,251,641 €
263 % *
Non-current Assets (€)
4,223,088 €185 % *
CurrentAssets (€)
2,375,290 €1,180 % *